Home  >  Products  >  PNPO (pyridoxamine 5'-phosphate oxidase) Blocking Peptide (the N terminal of protein) (100ug)
PNPO (pyridoxamine 5'-phosphate oxidase) Blocking Peptide (the N terminal of protein) (100ug)

PNPO (pyridoxamine 5'-phosphate oxidase) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PNPO antibody (Catalogue #: ARP58515_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP58515
Size: 100 ug
Weight: 29kDa
Gene: 55163
Format: Lyophilized powder
Target: PNPO catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine.Vitamin B6, or pyridoxal 5-prime-phosphate (PLP), is critical for normal cellular function, and some cancer cells have notable differences in vitamin B6 metabolism compared to their normal counterparts. The rate-limiting enzyme in vitamin B6 synthesis is pyridoxine-5-prime-phosphate (PNP) oxidase (PNPO; EC 1.4.3.5).[supplied by OMIM].
Alternative names: FLJ10535; PDXPO
See Full Product Listings >